EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Taking everything into account, EQS scores 6 out of 10 in our fundamental rating. EQS was compared to 12 industry peers in the Health Care Technology industry. EQS gets an excellent profitability rating and is at the same time showing great financial health properties. EQS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
Each year in the past 5 years EQS has been profitable.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 11.94%, EQS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
The Return On Equity of EQS (21.46%) is better than 81.82% of its industry peers.
EQS's Return On Invested Capital of 16.59% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
EQS had an Average Return On Invested Capital over the past 3 years of 17.88%. This is significantly above the industry average of 7.76%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.94% | ||
| ROE | 21.46% | ||
| ROIC | 16.59% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
1.3 Margins
EQS has a Profit Margin of 21.42%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of EQS has grown nicely.
EQS has a Operating Margin of 25.14%. This is amongst the best in the industry. EQS outperforms 100.00% of its industry peers.
EQS's Operating Margin has been stable in the last couple of years.
EQS's Gross Margin of 68.57% is on the low side compared to the rest of the industry. EQS is outperformed by 63.64% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.14% | ||
| PM (TTM) | 21.42% | ||
| GM | 68.57% |
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EQS has more shares outstanding
The number of shares outstanding for EQS has been increased compared to 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.77 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS's Altman-Z score of 3.77 is fine compared to the rest of the industry. EQS outperforms 72.73% of its industry peers.
EQS has a debt to FCF ratio of 1.70. This is a very positive value and a sign of high solvency as it would only need 1.70 years to pay back of all of its debts.
The Debt to FCF ratio of EQS (1.70) is better than 63.64% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that EQS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.20, EQS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.7 | ||
| Altman-Z | 3.77 |
ROIC/WACC2.28
WACC7.29%
2.3 Liquidity
EQS has a Current Ratio of 1.22. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Current ratio of 1.22. This is in the lower half of the industry: EQS underperforms 63.64% of its industry peers.
A Quick Ratio of 1.13 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Quick ratio of 1.13. This is in the lower half of the industry: EQS underperforms 63.64% of its industry peers.
The current and quick ratio evaluation for EQS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.70% over the past year.
Measured over the past years, EQS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 2.65% in the last year.
EQS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.16% yearly.
EPS 1Y (TTM)1.7%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-5.61%
Revenue 1Y (TTM)2.65%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-3.02%
3.2 Future
The Earnings Per Share is expected to grow by 8.38% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.58% on average over the next years.
EPS Next Y-27.4%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.76, the valuation of EQS can be described as very reasonable.
Based on the Price/Earnings ratio, EQS is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.47. EQS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 15.90 indicates a correct valuation of EQS.
Based on the Price/Forward Earnings ratio, EQS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
EQS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.76 | ||
| Fwd PE | 15.9 |
4.2 Price Multiples
63.64% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 72.73% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.07 | ||
| EV/EBITDA | 7.72 |
4.3 Compensation for Growth
The excellent profitability rating of EQS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.39%, EQS has a reasonable but not impressive dividend return.
In the last 3 months the price of EQS has falen by -21.71%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.80, EQS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, EQS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
5.2 History
On average, the dividend of EQS grows each year by 8.96%, which is quite nice.
Dividend Growth(5Y)8.96%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
36.73% of the earnings are spent on dividend by EQS. This is a low number and sustainable payout ratio.
The dividend of EQS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP36.73%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EQUASENS
EPA:EQS (2/5/2025, 10:17:50 AM)
36.45
-0.15 (-0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners12.92%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap552.95M
Analysts83.33
Price Target71.04 (94.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
Yearly Dividend1.15
Dividend Growth(5Y)8.96%
DP36.73%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.02%
EPS NY rev (3m)-14.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.57%
Revenue NY rev (3m)-3.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.76 | ||
| Fwd PE | 15.9 | ||
| P/S | 2.52 | ||
| P/FCF | 14.07 | ||
| P/OCF | 9.58 | ||
| P/B | 2.52 | ||
| P/tB | 6.22 | ||
| EV/EBITDA | 7.72 |
EPS(TTM)3.1
EY8.5%
EPS(NY)2.29
Fwd EY6.29%
FCF(TTM)2.59
FCFY7.11%
OCF(TTM)3.8
OCFY10.44%
SpS14.49
BVpS14.45
TBVpS5.86
PEG (NY)N/A
PEG (5Y)0.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.94% | ||
| ROE | 21.46% | ||
| ROCE | 19.33% | ||
| ROIC | 16.59% | ||
| ROICexc | 20.52% | ||
| ROICexgc | 47.01% | ||
| OM | 25.14% | ||
| PM (TTM) | 21.42% | ||
| GM | 68.57% | ||
| FCFM | 17.88% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
ROICexc(3y)23.8%
ROICexc(5y)24.68%
ROICexgc(3y)70.74%
ROICexgc(5y)71.14%
ROCE(3y)20.83%
ROCE(5y)21.18%
ROICexcg growth 3Y-16.59%
ROICexcg growth 5Y-12.82%
ROICexc growth 3Y-7.85%
ROICexc growth 5Y-8.24%
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.7 | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 135.67% | ||
| Cap/Sales | 8.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.86% | ||
| Profit Quality | 83.51% | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.77 |
F-Score6
WACC7.29%
ROIC/WACC2.28
Cap/Depr(3y)98.83%
Cap/Depr(5y)145.04%
Cap/Sales(3y)6.18%
Cap/Sales(5y)8.15%
Profit Quality(3y)93.06%
Profit Quality(5y)90.44%
High Growth Momentum
Growth
EPS 1Y (TTM)1.7%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-5.61%
EPS Next Y-27.4%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EPS Next 5YN/A
Revenue 1Y (TTM)2.65%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-3.02%
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
EBIT growth 1Y0.1%
EBIT growth 3Y6.19%
EBIT growth 5Y7.25%
EBIT Next Year-4.45%
EBIT Next 3Y14.95%
EBIT Next 5YN/A
FCF growth 1Y-15.93%
FCF growth 3Y12.59%
FCF growth 5Y17.34%
OCF growth 1Y1.3%
OCF growth 3Y6.93%
OCF growth 5Y14.97%